About Neox Clinical Research
Neox Clinical Research is a Healthcare company based in Prague (Czechia) founded in 2004, and was acquired by Emmes in December 2020. Full-service CRO offering clinical development services from Phase I - IV and geographic focus in Central and Eastern Europe. Neox Clinical Research offers products and services including Biostatistics Services, Clinical Data Management, Clinical Trial Management, Endpoint Solutions, and Pharmacovigilance. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is The Emmes Company, LLC.
Company details
Neox Clinical Research offers clinical development services for pharmaceutical, biotechnology and medical device companies and other CROs in Europe, with a special focus on Central and Eastern Europe. Their service portfolio includes project management, site contracting, clinical monitoring, data management and biostatistics, medical monitoring, medical writing, pharmacovigilance and safety, quality assurance and audits, regulatory and ethics committee submissions, study rescue and others. They claim to have significant experience in conducting trials in oncology, cardiovascular and CNS diseases. They operate independently and through their CRO partners all across Europe.
- Headquarters Prague, Czechia
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website neoxcro.com
- Social LinkedIn Facebook
- Acquired by Emmes (Dec 2020)
- Legal Name The Emmes Company, Llc
Products & Services of Neox Clinical Research
Neox Clinical Research offers a comprehensive portfolio of products and services, including Biostatistics Services, Clinical Data Management, Clinical Trial Management, Endpoint Solutions, and Pharmacovigilance.
Provides statistical analysis for clinical research studies
Manages data collection and integrity in trials
Oversees execution of clinical studies globally
Delivers tools for trial endpoints and outcomes
Monitors drug safety and adverse events
Generates evidence from real-world data sources
Investors in Neox Clinical Research
Neox Clinical Research has secured backing from 1 investor. Prominent investors backing the company include Emmes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Outsourced contract research organization services are provided to clients. | 1977 | emmes.com | United States |
Investor details for Neox Clinical Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Neox Clinical Research
2 dated milestones of Neox Clinical Research across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Neox Clinical Research is founded.
- Exit Acquired by Emmes.
Web traffic of Neox Clinical Research
Websites that share an audience with Neox Clinical Research (neoxcro.com).
Websites whose visitors overlap most with Neox Clinical Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facebook.com | 100% | 12.1B | #3 | View details | |
netmahal.com | netmahal.com | 100% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neox Clinical Research
Neox Clinical Research was founded in 2004.
Neox Clinical Research is headquartered in Prague, Czechia.
Neox Clinical Research offers clinical development services for pharmaceutical, biotechnology and medical device companies and other CROs in Europe, with a special focus on Central and Eastern Europe. Their service portfolio includes project management, site contracting, clinical monitoring, data management and biostatistics, medical monitoring, medical writing, pharmacovigilance and safety, quality assurance and audits, regulatory and ethics committee submissions, study rescue and others. They claim to have significant experience in conducting trials in oncology, cardiovascular and CNS diseases. They operate independently and through their CRO partners all across Europe.
Neox Clinical Research offers Biostatistics Services, Clinical Data Management, Clinical Trial Management, Endpoint Solutions, and 2 more products and services.
Neox Clinical Research has 1 investor. Key investors include Emmes.
Neox Clinical Research operates through The Emmes Company, Llc.
Yes. Neox Clinical Research was acquired by Emmes in December 2020.